Summary
During a send-off in the Oval Office, Elon Musk addressed allegations from a New York Times report claiming he frequently used ketamine during the 2024 campaign, dismissing the publication’s credibility. He acknowledged having a prescription for ketamine but contradicted the report by stating he uses it infrequently to manage depression. As Musk concludes his role overseeing the Department of Government Efficiency in the Trump administration, he has faced criticism regarding his drug use and its potential impact on his businesses, although he maintains that execution is what truly matters.
Full Article
